UnknownPhase 4

Functional Improvement and UTC of the Achilles Tendon After Sodium Hyaluronate Injection for Plantaris Syndrome

United Kingdom33 participantsStarted 2017-03-20

Plain-language summary

This is a study to assess the benefit of sodium hyaluronate (Ostenil) injection for plantaris friction syndrome (PFS) associated with midportion Achilles tendinopathy. Functional outcome scores will be recorded prior to treatment and at regular intervals up to 2 years. Changes in tendon structure will be assessed using ultrasonographic tissue characterisation (UTC). UTC will be performed prior to treatment and also at regular intervals up to 6 months following injection.

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 18-75 years * Able to provide informed consent * Diagnosis of PFS requiring sodium hyaluronate injection * Able to follow physiotherapy instructions Exclusion Criteria: * Previous Achilles tendon surgery * Previous injection therapy for Achilles midportion tendinopathy * Age \< 18 \>75 years * Active local infection * Active bleeding disorder or anticoagulant therapy * Allergies to lignocaine or sodium hyaluronate * Active deep vein thrombosis

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Ultrasound Tissue Characterisation (UTC)

Timeframe: up to 6 months post intervention

Trial details

NCT IDNCT03077009

SponsorFortius Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-03-20

Contact for this trial

Mary Jones, MSc

44 (0) 203 195 2341 mary.jones@fortiusclinic.com

View on ClinicalTrials.gov More Plantaris Friction Syndrome trials